The efficacy of smoking cessation strategies in people with chronic obstructive pulmonary disease: Results from a systematic review

Respiratory Medicine

Volumn 98, Issue 9, 2004, Pages 805-815

  Wagena, E J ^a,e   van der Meer, R M ^b   Ostelo, R J W G ^c   Jacobs, J E ^a,d   van Schayck, C P ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b STIVORO for a Smoke free Future   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^e Pulmonary Rehabilitation Centre Hornerheide   (Netherlands)

Author keywords

COPD; Smoking cessation; Systematic review

Indexed keywords

AMFEBUTAMONE; IPRATROPIUM BROMIDE; NICOTINE; NICOTINE GUM; PLACEBO;

BEHAVIOR THERAPY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; DATA ANALYSIS; DATA BASE; DISEASE COURSE; HUMAN; NICOTINE REPLACEMENT THERAPY; OUTCOMES RESEARCH; PATIENT COUNSELING; PRIORITY JOURNAL; RELAPSE; REVIEW; RISK REDUCTION; SMOKING CESSATION; SYSTEMATIC REVIEW;

EID: 4043124780     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2004.06.001     Document Type: Article

References (37)

1. Pauwels R.A. Buist A.S. Calverley P.M. Jenkins C.R. Hurd S.S. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO global initiative for chronic obstructive lung disease (GOLD) Workshop summary Am J Respir Crit Care Med 163 2001 1256-1276
2. Roche N. Huchon G.J. Current issues in the management of chronic obstructive pulmonary disease Respirology 2 1997 215-229
3. US Department of Health and Human Services. The health consequences of smoking: chronic obstructive lung disease. Rockville, MD: Office on Smoking and Health, Department of Health and Human Services; 1984. Report No. (CDC) 8.416
4. Burchfiel C. Marcus E. Curb J. Maclean C. et al. Effects of smoking and smoking cessation on longitudinal decline in pulmonary function Am J Respir Crit Care Med 151 1995 1778-1785
5. Camilli A.E. Burrows B. Knudson R.J. Lyle S.K. Lebowitz M.D. Longitudinal changes in forced expiratory volume in one second in adults Am Rev Respir Dis 135 1987 794-799
6. Fletcher C.M. Peto R. Tinker C.M. Speizer F.E. The natural history of chronic bronchitis and emphysema 1976 Oxford University Press Oxford
7. Muers M.F. Quitting smoking and lungs Lancet 354 1999 177-178
8. Pelkonen M. Notkola I-.L. Tukiainen H. Tervahauta M. Tuomilehto J. Nissinen A. Smoking cessation, decline in pulmonary function and total mortality: a 30 year follow up study among the Finnish cohorts of the seven countries study Thorax 56 2001 703-707
9. Xu X. Dockery D.W. Ware J.H. Speizer F.E. Ferris B.G. Effects of cigarette smoking on rate of loss of pulmonary function in adults: a longitudinal assessment Am Rev Respir Dis 146 1992 1345-1348
10. Tashkin D.P. Detels R. Simmons M. Liu. et al. The UCLA population studies of chronic obstructive respiratory disease: XI. Impact of air pollution and smoking on annual change in forced expiratory volume in one second. Am J Respir Crit Care Med 1994 149 1209-17
11. Tager I.B. Segal M.R. Speizer F.E. Weiss S.T. The natural history of forced expiratory volumes: effect of cigarette smoking and respiratory symptoms Am Rev Respir Dis 138 1988 837-849
12. Anthonisen N.R. Connett J.E. Kiley J.P. et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study JAMA 272 1994 1497-1505
13. Sherrill D. Holberg C. Enright P. Lebowitz M. Burrows B. Longitudinal analysis of the effects of smoking onset and cessation on pulmonary function Am J Respir Crit Care Med 149 1994 591-597
14. Soejima K. Yamaguchi K. Kohda E. et al. Longitudinal follow-up study of smoking-induced lung density changes by high resolution computed tomography Am J Respir Crit Care Med 161 2000 1264-1273
15. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995 152 S77-121
16. BTS guidelines for the management of chronic obstructive pulmonary disease: the COPD guideline group of the standards of care committee of the BTS. Thorax 1997 52(suppl. 5) S1-28
17. Siafakas N.M. Vermeire P. Pride N.B. et al. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force Eur Respir J 8 1995 1398-1420
18. Van der Meer R. Wagena E.J. Ostelo R. Jacobs J. Van Schayck CP. Smoking cessation for people with chronic obstructive pulmonary disease (Cochrane review). In: The Cochrane Library, Issue 2. Oxford: Update Software; 2003.
19. Hughes J.R. Stead L.F. Lancaster T. Antidepressants for smoking cessation (Cochrane review). In: The Cochrane Library, Issue 2. Oxford: Update Software; 2002.
20. Jarvis M.J. Powell S.R. Marsh H.S Browning D. Aristides M. Brown A. A meta-analysis of clinical studies confirms the effectiveness of bupropion SR (Zyban™) in smoking cessation. Poster Presentation at the 8th Annual Meeting of the Society for Research on Nicotine and Tobacco, Savannah, Georgia, February 20-23, 2002.
21. Perruchoud A.P. Townsend J. Lorand D. The efficacy of bupropion hydrochloride sustained release (SR) for smoking cessation is consistent in placebo-controlled studies Eur Respir J 20 suppl. 38 2002 579s
22. Manheimer E. Anderson D. Survey of public information about ongoing clinical trials funded by industry: evaluation of completeness and accessibility BMJ 325 2002 528-531
23. McCray A.T. Better access to information about clinical trials Ann Intern Med 133 2000 609-614
24. Anderson D. Costa I. Dickersin K. TrialsCentral, an online register of clinical trials registers. Control Clin Trials 2001 22 S40
25. Verhagen A.P. de Vet H.C. de Bie R.A. et al. The Delphi list: a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus J Clin Epidemiol 51 1998 1235-1241
26. Wintertree Software Inc. Review Manager 4.2.2. In: The Cochrane Collaboration; 2003.
27. Crowley T.J. Macdonald M.J. Walter M.I. Behavioral anti-smoking trial in chronic obstructive pulmonary disease patients Psychopharmacology 119 1995 193-204
28. Brandt C.J. Ellegaard H. Joensen M.B. Kallan F.V. Sorknaes A.D. Tougaard L. Effect of diagnosis of "smoker's lung" Lancet 349 1997 253
29. Pederson L.L. Wanklin J.M. Lefcoe N.M. The effects of counseling on smoking cessation among patients hospitalized with chronic obstructive pulmonary disease: a randomized clinical trial Int J Addiction 26 1991 107-119
30. Tashkin D.P. Kanner R. Bailey W. et al. Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial Lancet 357 2001 1571-1575
31. Murray R.P. Connett J.E. Rand C.S. Pan W. Anthonisen N.R. Persistence of the effect of the lung health study (LHS) smoking intervention over eleven years Prev Med 35 2002 314-319
32. Silagy C. Lancaster T. Stead L. Mant D. Fowler G. Nicotine replacement therapy for smoking cessation (Cochrane review). In: The Cochrane Library, Issue 2. Oxford: Update Software; 2002.
33. Balfour D.J.K. The pharmacology underlying pharmacotherapy for tobacco dependence: focus on bupropion Int J Clin Pract 55 2001 53-57
34. Scanlon P.D. Connett J.E. Waller L.A. Altose M.D. Bailey W.C. Buist A.S. Smoking cessation: effects on symptoms, spirometry and future trends in COPD Thorax 56 suppl. II 2001 ii7-ii10
35. Lancaster T. Stead L. Silagy C. Sowden A. Effectiveness of interventions to help people stop smoking: findings from the Cochrane library BMJ 321 2000 355-358
36. Covey L.S. Sullivan M.A. Johnston J.A. Glassman A.H. Robinson M.D. Adams D.P. Advances in non-nicotine pharmacotherapy for smoking cessation Drugs 59 2000 17-31
37. Hughes J.R. Distinguishing nicotine dependence from smoking. Why it matters to tobacco control and psychiatry Arch Gen Psychiatry 58 2001 817-818